breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of stage 1 to 3 hormone-dependent breast cancer (histology report), without recurrence and metastasis to distant sites Taking tamoxifen or aromatase inhibitor drugs for at least 3 months The type of medication must be stable for at least 2 months before the start of the study. Development or worsening of musculoskeletal pain following initiation of endocrine therapy Experiencing musculoskeletal pain for at least 2 months and at least 15 days per month Having pain with an intensity of at least 3 on a scale of 0 to 10 (sensory dimension of the Persian version of the Short Pain Questionnaire) in the week before the start of the study Iranian nationality, resident of Kashan and its suburbs Postmenopausal (age 60 years or older, history of oophorectomy, history of hysterectomy, or amenorrhea for at least 12 months) At least 4 weeks have passed since the completion of surgical, chemotherapy, and radiotherapy treatments. Organ health in the earlobe area
Exclusion criteria
Exclusion criteria: Any type of surgery, musculoskeletal disease, orthopedic or neurological problems during the study Performing any type of intense physical activity or starting a sports activity during the study Use of corticosteroids or opioids during the study Allergy to glue Hospitalization due to physical or mental problems during the study Performing physiotherapy during the study Taking nutritional supplements during the study (except calcium and vitamin D) Changes in endocrine treatment plan during the study Combined use of other complementary therapies Withdrawal from further cooperation during the study Failure to meet the criteria regarding the average daily pressure applied to the heads during each week of intervention (less than 6 minutes per day) Experiencing serious stress, lack of access, death engaging in professional sports activities having fibromyalgia, arthritis and inflammatory arthritis requiring medication, active cancer, rheumatoid arthritis, peripheral nerve problems in the limbs, cognitive impairment, and lymphedema based on patient records and self-report. use of narcotics and corticosteroids using acupuncture in the past 6 months amputation, fracture, or bone surgery within the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Musculoskeletal pain score. Timepoint: At the beginning of the study, after the end of the intervention, and 4 weeks after the end of the intervention. Method of measurement: Persian version of the Brief Pain Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain interference score. Timepoint: weekely. Method of measurement: Report of patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kashan University of Medical Sciences